Facet Biotech, the Redwood City drug development company that is facing a proxy fight, now has has a new majority shareholder, according to a regulatory filing Wednesday.
The Baupost Group, a Boston investment company run by Seth Klarman, disclosed owning Read the rest of this entry »
Facet Biotech of Redwood City notified the SEC Tuesday that one of its shareholders, Roderick Wong, who controls some 124,828 shares, plans to offer five of his own nominees to be elected to the company’s board of directors, including himself.
The company said that its board and management, “are committed to Read the rest of this entry »
Subscribe via RSS all feeds - Tech feed - O'Brien feed - Docu-Drama feed - Pink Slip 2.0 feed
